# GLP-1s after a gastric sleeve or bypass · PepVault guides

Source: https://pepvault.app/guides/glp-1-after-bariatric-surgery

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1

Reviewed November 2026 21 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Do GLP-1s work after a gastric sleeve or bypass? The trials on regain, the labels' doses side by side, side effects after surgery, and sleeve vs GLP-1 numbers.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 21
- **Questions:** 7
- **Compounds:** 3

## The short answer

Yes. In BARI-STEP, the first placebo-controlled trial of semaglutide 2.4 mg after a sleeve or bypass, people whose surgery had worked poorly lost 18.0% of their weight over 68 weeks, against 0.4% on placebo. Clinic records show 12 to 18% on tirzepatide. The trials used the labels' usual step-up. On its own, surgery still takes off more. Your surgical or obesity team decides whether a drug fits, and which.

Every number checked at its primary source · Nov 20, 2026 · [21 sources](https://pepvault.app/guides/glp-1-after-bariatric-surgery#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Moderate for semaglutide and liraglutide after surgery (two small placebo-controlled trials of 70 people each, one 68 weeks long); very low for tirzepatide (five observational studies, 6 to 12 months). Sleeve or bypass versus a GLP-1 rests on large records studies, not a finished randomized trial.

## Do GLP-1s work after gastric sleeve or bypass surgery?

Yes, and the evidence is now a **randomized controlled trial** (people assigned to drug or placebo by chance; see pepvault.app/glossary/randomized-controlled-trial), not only clinic records. BARI-STEP, run at University College London, enrolled 70 adults at least a year after a gastric bypass or sleeve gastrectomy who had lost less than 20% of their weight since surgery[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). They averaged seven years past surgery, 79% had a sleeve, and mean BMI was 41.5[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). Everyone got diet advice aiming at a 500-calorie daily deficit; half also got semaglutide 2.4 mg weekly, the Wegovy dose (pepvault.app/drugs/wegovy), and half a placebo, for 68 weeks[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1).

| At week 68, BARI-STEP[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1) | Semaglutide 2.4 mg | Placebo |
| --- | --- | --- |
| Change in body weight | −18.0% | +0.4% |
| Lost 10% or more | 85.3% | 6.9% |
| Lost 15% or more | 61.8% | 6.9% |
| Lost 20% or more | 47.1% | 3.4% |

The gap between the arms was 19.2 percentage points, about 21.7 kg[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). The same team's earlier trial, BARI-OPTIMISE, gave liraglutide 3.0 mg daily (the Saxenda dose, pepvault.app/drugs/saxenda) to 70 similar patients for 24 weeks: −8.8% against −0.5% on placebo[2](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-2). In GRAVITAS, liraglutide 1.8 mg lowered HbA1c (the three-month blood sugar average, pepvault.app/glossary/hba1c) by 1.22 points more than placebo in people whose type 2 diabetes stayed or came back after surgery[3](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-3).

Tirzepatide (Zepbound, Mounjaro) has no placebo-controlled trial after surgery yet. A 2026 systematic review found five **observational studies** (records of people already treated, without a comparison group chosen by chance; pepvault.app/glossary/observational-study), with 12.0% to 18.1% weight loss at 6 to 12 months, and rated the certainty of the evidence very low[5](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-5). Pooled clinic studies put semaglutide after surgery at about 9 to 11% and tirzepatide at about 14%[6](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-6) [7](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-7). In one Boston clinic's records, people with a past bypass lost 13.6% at a year on semaglutide, against 10.1% in people with no surgery; a past sleeve made no clear difference[16](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-16).

<!--promo-->

PepVault logs each weigh-in, and its weight chart can mark when your protocol started and each dose change, so your team can see what the drug added on top of your surgery. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-after-bariatric-surgery-inli&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault logs each weigh-in, and its weight chart can mark when your protocol started and each dose change, so your team can see what the drug added on top of your surgery.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## How common is weight regain after a sleeve or bypass?

Common. In the PCORnet study of 65,093 US patients, average total weight loss was 31.2% a year after a bypass and 25.2% after a sleeve; at five years it was 25.5% and 18.8%[8](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-8). After a sleeve, that is about a quarter of the loss given back. A 2025 review puts recurrent weight gain at 15 to 40% of patients after surgery[7](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-7).

In 2026, 66 international experts agreed on terms for it: "suboptimal" is the preferred word, a response to surgery counts as too small below 10% total weight loss at 12 months, and "recurrent weight gain" means regaining more than 25% of the weight lost, counted from the lowest point[9](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-9). A GLP-1 drug fits here because GLP-1 is one of the gut's own fullness hormones, and poor weight loss after surgery goes with lower GLP-1 levels in the blood[2](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-2).

## Gastric sleeve vs GLP-1: which takes off more weight?

Surgery, by a wide margin in everyday care, and a narrower one against the best trial results. No finished trial has assigned people to surgery or a drug by chance, so the numbers below come from different studies and are not a head-to-head result[10](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-10) [11](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-11) [12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12) [13](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-13).

| Treatment | Where the number comes from | Weight lost |
| --- | --- | --- |
| Semaglutide 2.4 mg (Wegovy) | STEP 1 trial, 68 weeks, as the Wegovy label reports it[12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12) | 14.9% (placebo 2.4%) |
| Tirzepatide 15 mg (Zepbound) | SURMOUNT-1 trial, 72 weeks, as the Zepbound label reports it[13](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-13) | 20.9% (placebo 3.1%) |
| Semaglutide, everyday care | Two New York health systems, years 1, 2, 3[10](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-10) | 5.4%, 6.5%, 7.4% |
| Tirzepatide, everyday care | Same study, years 1 and 2[10](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-10) | 9.1%, 10.8% |
| Sleeve gastrectomy | Same study, years 1, 2, 3[10](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-10) | 24.4%, 22.4%, 22.0% |
| Gastric bypass | Same study, years 1, 2, 3[10](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-10) | 29.8%, 28.1%, 28.4% |

Many people stop the drugs in everyday care. Counting only those with a full year of prescriptions, semaglutide reached 7.2% and tirzepatide 11.7% at one year, still well under surgery[10](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-10). In 45,093 US adults with type 2 diabetes and a BMI of 35 or more, the chance of losing 20% with a normal HbA1c at one year was 3.0% on semaglutide, 13.2% on tirzepatide and 24.0% after a sleeve; the sleeve group was younger and heavier, and had more emergency visits in that year[11](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-11). A Cleveland Clinic trial is assigning about 140 people to surgery, semaglutide or tirzepatide by chance, with its main results due after July 2027[14](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-14). The two trials: pepvault.app/research/semaglutide-step-1-2021 and pepvault.app/research/tirzepatide-surmount-1-2022.

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)
- [MASH](https://pepvault.app/glossary/mash)

## What dose do people take after surgery?

The same labelled step-up as anyone else. None of the four labels has a separate schedule for people after surgery, and none lists past surgery as a reason not to use the drug[12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12) [13](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-13) [15](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-15) [17](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-17). These are the labels' doses, not a dose for any one person (pepvault.app/drugs/ozempic, pepvault.app/drugs/mounjaro, pepvault.app/drugs/zepbound).

| Label | Approved for | Start | Steps | Highest dose |
| --- | --- | --- | --- | --- |
| Wegovy (semaglutide)[12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12) | Weight; heart risk; MASH | 0.25 mg weekly for 4 weeks | 0.5, 1, 1.7 mg, 4 weeks each; 2.4 mg from week 17 | 7.2 mg, after 4 weeks on 2.4 mg |
| Ozempic (semaglutide)[15](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-15) | Type 2 diabetes; heart and kidney risk in type 2 diabetes | 0.25 mg weekly for 4 weeks | 0.5 mg, then 1 mg and 2 mg if needed, 4 weeks apart | 2 mg |
| Zepbound (tirzepatide)[13](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-13) | Weight; sleep apnea | 2.5 mg weekly for 4 weeks | Up 2.5 mg at a time, at least 4 weeks apart; 5, 10 or 15 mg to stay on | 15 mg |
| Mounjaro (tirzepatide)[17](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-17) | Type 2 diabetes; heart risk in type 2 diabetes | 2.5 mg weekly | Up 2.5 mg at a time, at least 4 weeks apart | 15 mg |

BARI-STEP followed the same 16-week climb to 2.4 mg. Every participant who finished reached 2.4 mg; five of them were then kept on a lower dose (0.5 to 1.7 mg) because of side effects, and a sixth stepped down before leaving the trial[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). In an Italian group of 34 people with regain after a bariatric procedure (32 of them surgical), tirzepatide was used at 2.5 to 10 mg a week[4](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-4). Which drug, how fast to climb and where to stop is set by the prescriber, and the labels allow a slower climb or a lower dose to stay on when a step is hard to tolerate[12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12) [13](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-13). Full schedules: pepvault.app/guides/wegovy-and-ozempic-dosage and pepvault.app/guides/tirzepatide-dosage.

<!--promo-->

Turn on a dose reminder and PepVault reminds you on your shot day at the time you set, unless the dose is already logged, and each dose you log keeps its amount in your history. [Set reminders in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-after-bariatric-surgery-inli&mt=8)

<!--/promo-->

## Does a GLP-1 absorb differently after a sleeve or bypass?

The shots do not depend on the stomach: Wegovy, Ozempic, Zepbound and Mounjaro are injected under the skin and taken up from there into the blood[12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12) [13](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-13). The pills are different. Oral semaglutide (Rybelsus and the Wegovy pill) carries an absorption helper called SNAC that works only in the stomach, where the tablet dissolves[18](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-18). A 2026 review argues that a smaller stomach, weaker stomach contractions and faster emptying after surgery could lower how much gets in, and suggests the injection until studies measure it; no study has yet measured blood levels of the pill after surgery[18](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-18). The pill itself is covered in pepvault.app/guides/the-wegovy-pill.

## Are the side effects different after surgery?

Mostly the familiar ones. In BARI-STEP the share of people with any side effect was about the same in both arms, 97% on semaglutide and 94% on placebo, with no new safety concern after surgery[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). The stomach effects ran higher on the drug, semaglutide against placebo[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1):

- **Nausea:** 68.6% against 22.9%.
- **Lower appetite:** 42.9% against 11.4%.
- **Constipation:** 37.1% against 22.9%.
- **Diarrhea:** 60.0% against 40.0%.
- **Vomiting:** 28.6% against 17.1%.

Two points are specific to surgery. Past bariatric surgery is a risk factor for low blood sugar: in the SELECT heart trial, people with that history had more serious low blood sugar on Wegovy, 2.3% (2 of 87), against none of 97 on placebo[12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12). And in BARI-STEP one person on semaglutide developed restrictive eating, which led to stopping the drug[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). Lows after a bypass: pepvault.app/guides/glp-1-low-blood-sugar. Smaller meals, eating slowly and stopping at the first sign of fullness help most in the step-up weeks (more at pepvault.app/peptides/semaglutide/side-effects).

**Commonly reported:** in patients' own accounts, not trial measures, the old pre-surgery hunger quieting again within the first weeks, and fullness arriving after fewer bites than before the drug.

**When to get help** Shakiness, sweating, confusion or a fast heartbeat (the label's signs of low blood sugar), or being unable to keep fluids down, is a reason to call your care team that day[12](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-12).

## Drug or revision surgery: who decides?

Your surgical or obesity team, with you. The 2026 expert consensus agreed unanimously that care after surgery is individual and that it is appropriate for specialists to prescribe weight-loss drugs to these patients[9](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-9). The other option is a second operation (revisional surgery). Weight loss after a revision ranges from 7.8% to 37.7% in the meta-analysis the BARI-STEP authors cite, and they argue 68 weeks of semaglutide may rival it[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). In one group of 250 people with regain, those who had a second operation (a sleeve converted to a bypass, or a bypass revised) had lost 17.5% at two years, against 2.8% for those given semaglutide, but that was a records study without safety data for the operations, and its semaglutide result is far below BARI-STEP's[19](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-19) [1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). Going into a revision on a GLP-1 raises the anesthesia question: pepvault.app/guides/glp-1-before-surgery.

Tirzepatide's trials are still coming: a Vanderbilt trial (GRABS) assigned 33 people after a bypass to tirzepatide or usual care by chance, and has posted no results as of November 20, 2026[21](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-21); a placebo-controlled tirzepatide trial in Porto was registered in September 2026 and plans to start in January 2027[20](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-20). And muscle is worth watching: in BARI-STEP, of about 21 kg lost on semaglutide, 15.8 kg was fat and 5.5 kg lean tissue, and the authors call for strength and function testing next[1](https://pepvault.app/guides/glp-1-after-bariatric-surgery#source-1). Protein and strength work are the usual answer (pepvault.app/guides/muscle-on-a-glp-1). Staying on the drug: pepvault.app/guides/keeping-weight-off-after-a-glp-1.

<!--promo-->

If your surgical dietitian gave you a protein target, type it into the nutrition target in your PepVault profile, and the app tracks each day against your number instead of its own. [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-after-bariatric-surgery-inli&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Stanley C, Mallik R et al. Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial (BARI-STEP). Nat Med. 2026;32(7):2662-2672. [PubMed 42174253](https://pubmed.ncbi.nlm.nih.gov/42174253/)
2. Mok J et al. Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial. JAMA Surg. 2023;158(10):1003-1011. [PubMed 37494014](https://pubmed.ncbi.nlm.nih.gov/37494014/)
3. Miras AD et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(7):549-559. [PubMed 31174993](https://pubmed.ncbi.nlm.nih.gov/31174993/)
4. Vinciguerra F et al. Tirzepatide for recurrent weight gain after bariatric procedures: real-world evidence of efficacy and safety. Obes Surg. 2026;36(7):3697-3704. [PubMed 42247124](https://pubmed.ncbi.nlm.nih.gov/42247124/)
5. Alfuhaydi GL, Alahmed AA, Alfayez OM. Clinical outcomes of tirzepatide after metabolic bariatric surgery: a systematic review. Diabetes Metab Syndr Obes. 2026;19:656297. [PubMed 43022657](https://pubmed.ncbi.nlm.nih.gov/43022657/)
6. Santos-Pereira M, Frutuoso JF et al. Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2026;17:1870008. [PubMed 42718598](https://pubmed.ncbi.nlm.nih.gov/42718598/)
7. Osorio Manyari AA et al. Effects of semaglutide and tirzepatide on recurrent weight gain after bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2025;35(12):5596-5605. [PubMed 41313431](https://pubmed.ncbi.nlm.nih.gov/41313431/)
8. Arterburn D et al. Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med. 2018;169(11):741-750. [PubMed 30383139](https://pubmed.ncbi.nlm.nih.gov/30383139/)
9. Wills MV et al. International expert consensus on definitions and management of weight recurrence and suboptimal response after metabolic and bariatric surgery: a Delphi study. Surg Obes Relat Dis. 2026;22(7):753-761. [PubMed 41963214](https://pubmed.ncbi.nlm.nih.gov/41963214/)
10. Brown A et al. Real-world effectiveness of semaglutide and tirzepatide compared with bariatric surgery. Obesity (Silver Spring). 2026;34(8):1583-1591. [PubMed 42345739](https://pubmed.ncbi.nlm.nih.gov/42345739/)
11. Leslie DB et al. 1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort study. Lancet Diabetes Endocrinol. 2026;14(8):638-648. [PubMed 42309121](https://pubmed.ncbi.nlm.nih.gov/42309121/)
12. Wegovy (semaglutide) injection and tablets, prescribing information. Novo Nordisk. DailyMed, June 30, 2026 (SPL version 19). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
13. Zepbound (tirzepatide) injection, prescribing information. Eli Lilly and Company. DailyMed, September 2, 2026 (SPL version 40). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
14. ClinicalTrials.gov. NCT06803888: Efficacy and safety of bariatric surgery, semaglutide once weekly, and tirzepatide once weekly in patients with obesity (sponsor Ali Aminian, Cleveland Clinic). Active, not recruiting; primary completion estimated July 2027 (record updated September 2026). [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06803888)
15. Ozempic (semaglutide) injection, prescribing information. Novo Nordisk. DailyMed, June 10, 2026 (SPL version 20). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
16. Medhati P et al. GLP-1RA in the real world: 1-year compliance and outcomes of semaglutide use in patients with or without previous history of bariatric surgery. Ann Surg. 2025. [PubMed 40334053](https://pubmed.ncbi.nlm.nih.gov/40334053/)
17. Mounjaro (tirzepatide) injection, prescribing information. Eli Lilly and Company. DailyMed, September 2, 2026 (SPL version 40). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
18. Dahan AE, Azran C, Dahan A. Is oral semaglutide a good fit for patients after metabolic bariatric surgery? A biopharmaceutical mechanistic perspective. Pharmaceutics. 2026;18(4):466. [PubMed 42076118](https://pubmed.ncbi.nlm.nih.gov/42076118/)
19. Rivero-Moreno Y et al. Revisional metabolic and bariatric surgery versus semaglutide: which strategy has greater efficacy for recurrent weight gain after primary bariatric surgery? Obes Surg. 2026;36(5):2361-2371. [PubMed 41906069](https://pubmed.ncbi.nlm.nih.gov/41906069/)
20. ClinicalTrials.gov. NCT07829198 (TirBaS): Efficacy of tirzepatide for weight management in patients with suboptimal weight loss after bariatric surgery, a randomized, double-blind, placebo-controlled trial (sponsor Universidade do Porto). Not yet recruiting; first posted September 18, 2026. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829198)
21. ClinicalTrials.gov. NCT06162715: GLP-1 receptor agonists post-bariatric surgery (GRABS) pilot trial (sponsor Vanderbilt University Medical Center). Randomized, open-label, 33 enrolled; primary completion October 10, 2026; no results posted (record updated November 18, 2026). [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06162715)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)

Retatrutide has no label, so no official alcohol rule. What its trials excluded, what the glucagon arm means for blood sugar, and what a rat study found.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)

## Related guides

- Guide · GLP-1s

  ### [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)

  What each trial tested for keeping weight off after a GLP-1: staying on, a lower dose, switching to a pill and exercise, with every result in one by-drug table.

  Read the guide
- Guide · GLP-1s

  ### [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)

  How much weight lost on a GLP-1 is lean mass: SURMOUNT-1, STEP 1, the apitegromab and bimagrumab add-on trials, and what guidance says on protein and training.

  Read the guide
- Guide · GLP-1s

  ### [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)

  Rarely. In weight-loss trials, readings under 54 mg/dL hit 0.3% on Zepbound and 0.6% on Foundayo, none on placebo. When the risk rises and what to do about it.

  Read the guide
- Guide · GLP-1s

  ### [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)

  Most people no longer stop a GLP-1 before surgery. What the labels, the 2024 multi-society guidance and the 2025 SPAQI consensus say, and when to restart.

  Read the guide
- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide
- Guide · GLP-1s

  ### [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)

  The Wegovy pill is daily semaglutide, FDA approved in December 2025. How to take it, its doses beside the weekly shot's, and OASIS 4 next to STEP 1.

  Read the guide
- Guide · GLP-1s

  ### [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)

  Wegovy and Ozempic dosage side by side: both FDA labels' four-week steps, the maintenance doses and the max, why they differ and what the trials saw per dose.

  Read the guide
- Guide · GLP-1s

  ### [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)

  Tirzepatide doses from 2.5 to 15 mg: the Mounjaro and Zepbound label steps, the 4-week rule, maintenance doses, pens and vials, and SURMOUNT-1 weight by dose.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)
- [MASH](https://pepvault.app/glossary/mash)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
